Mainz Biomed News

Mainz Biomed Analyst Ratings

BenzingaApr 12 09:56 ET

Analysts' Top Healthcare Picks: Mainz Biomed B.V. (MYNZ), Century Therapeutics (IPSC)

TipRanksApr 12 06:20 ET

Mainz Biomed Analyst Ratings

BenzingaMar 6 12:01 ET

HC Wainwright & Co. Maintains Buy on Mainz Biomed, Lowers Price Target to $3

BenzingaMar 6 12:03 ET

Analysts Are Bullish on Top Healthcare Stocks: Iterum Therapeutics (ITRM), Mainz Biomed B.V. (MYNZ)

TipRanksMar 6 11:30 ET

Mainz Biomed B.V.: Buy Rating With High CRC Detection Success and AI Integration

TipRanksDec 5, 2023 14:55 ET

Cantor Fitzgerald Cuts Mainz to Neutral, Cites Liquidity Concerns

Seeking AlphaNov 21, 2023 15:45 ET

Analysts Are Bullish on Top Healthcare Stocks: Mainz Biomed B.V. (MYNZ), Agile Therapeutics (AGRX)

TipRanksNov 21, 2023 12:20 ET

Mainz Biomed Analyst Ratings

BenzingaNov 21, 2023 07:47 ET

Analysts Offer Insights on Healthcare Companies: Mainz Biomed B.V. (MYNZ), Xencor (XNCR) and Biotricity (BTCY)

TipRanksNov 20, 2023 06:30 ET

HC Wainwright & Co. Maintains Buy on Mainz Biomed, Lowers Price Target to $5

BenzingaNov 20, 2023 06:11 ET

Mainz Biomed Analyst Ratings

BenzingaNov 20, 2023 06:09 ET

Cantor Fitzgerald Reiterates Overweight on Mainz Biomed, Maintains $9 Price Target

BenzingaSep 26, 2023 11:46 ET

Mainz Biomed Analyst Ratings

BenzingaSep 26, 2023 11:45 ET

HC Wainwright & Co. Maintains Buy on Mainz Biomed, Raises Price Target to $9

BenzingaSep 22, 2023 12:57 ET

Mainz Biomed Analyst Ratings

BenzingaSep 22, 2023 12:56 ET

H.C. Wainwright Sticks to Their Buy Rating for Mainz Biomed B.V. (MYNZ)

TipRanksSep 22, 2023 12:15 ET

Cantor Fitzgerald Reiterates Overweight on Mainz Biomed, Maintains $9 Price Target

BenzingaSep 14, 2023 09:05 ET

Mainz Biomed Analyst Ratings

BenzingaSep 14, 2023 09:04 ET

JonesTrading Sticks to Their Buy Rating for Mainz Biomed B.V. (MYNZ)

TipRanksSep 13, 2023 10:25 ET